

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.85493820 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.81096569 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.29726744 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.29726744 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.23112680 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.23112680 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.18071487 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 4.15318636 |
| 9 | response to peptidoglycan (GO:0032494) | 3.90710088 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.90466548 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.89590380 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.89590380 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.89590380 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.89590380 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.89590380 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.89590380 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86938389 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83295820 |
| 19 | response to interferon-beta (GO:0035456) | 3.82566842 |
| 20 | respiratory burst (GO:0045730) | 3.73013159 |
| 21 | response to interferon-alpha (GO:0035455) | 3.66810030 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.64035554 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54058384 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.53680264 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47046469 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43760335 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 3.41186207 |
| 28 | B cell mediated immunity (GO:0019724) | 3.30871590 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 3.30547560 |
| 30 | negative regulation of phagocytosis (GO:0050765) | 3.30194368 |
| 31 | mast cell activation (GO:0045576) | 3.28142635 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.25901783 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.25901783 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24845719 |
| 35 | defense response to protozoan (GO:0042832) | 3.24507368 |
| 36 | response to type I interferon (GO:0034340) | 3.24397470 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.24265360 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.21533126 |
| 39 | neutrophil activation (GO:0042119) | 3.19304105 |
| 40 | leukocyte aggregation (GO:0070486) | 3.15732938 |
| 41 | cellular response to interferon-beta (GO:0035458) | 3.15676366 |
| 42 | response to protozoan (GO:0001562) | 3.13021433 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.12743826 |
| 44 | detection of other organism (GO:0098543) | 3.10585742 |
| 45 | myeloid dendritic cell activation (GO:0001773) | 3.10147758 |
| 46 | granulocyte activation (GO:0036230) | 3.07137228 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.06523242 |
| 48 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.06277801 |
| 49 | lymphocyte chemotaxis (GO:0048247) | 3.05839476 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02804573 |
| 51 | cellular response to zinc ion (GO:0071294) | 3.01928595 |
| 52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01379540 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01252987 |
| 54 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.01178221 |
| 55 | detection of bacterium (GO:0016045) | 3.00021602 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 2.97093841 |
| 57 | actin nucleation (GO:0045010) | 2.95022987 |
| 58 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94547871 |
| 59 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94547871 |
| 60 | viral transcription (GO:0019083) | 2.94346976 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.93922217 |
| 62 | pinocytosis (GO:0006907) | 2.90353988 |
| 63 | cellular extravasation (GO:0045123) | 2.87927657 |
| 64 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.86818687 |
| 65 | positive regulation of macrophage differentiation (GO:0045651) | 2.86467404 |
| 66 | positive thymic T cell selection (GO:0045059) | 2.86336443 |
| 67 | response to muramyl dipeptide (GO:0032495) | 2.85652386 |
| 68 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84727720 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84200718 |
| 70 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.84173617 |
| 71 | regulation of tolerance induction (GO:0002643) | 2.83680349 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83439669 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82107138 |
| 74 | DNA deamination (GO:0045006) | 2.81629863 |
| 75 | regulation of mononuclear cell migration (GO:0071675) | 2.80298714 |
| 76 | translational termination (GO:0006415) | 2.79413667 |
| 77 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78624564 |
| 78 | mature B cell differentiation involved in immune response (GO:0002313) | 2.77828803 |
| 79 | regulation of lymphocyte migration (GO:2000401) | 2.77787783 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 2.75904656 |
| 81 | myeloid dendritic cell differentiation (GO:0043011) | 2.75791102 |
| 82 | T cell migration (GO:0072678) | 2.74226944 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 2.73489942 |
| 84 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.72992828 |
| 85 | detection of external biotic stimulus (GO:0098581) | 2.72647260 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71826207 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71713970 |
| 88 | endosome to melanosome transport (GO:0035646) | 2.68700797 |
| 89 | endosome to pigment granule transport (GO:0043485) | 2.68700797 |
| 90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.68566610 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67854641 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.66628126 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66245286 |
| 94 | positive regulation of interferon-beta production (GO:0032728) | 2.66033338 |
| 95 | definitive hemopoiesis (GO:0060216) | 2.66012318 |
| 96 | positive regulation of lymphocyte migration (GO:2000403) | 2.65185859 |
| 97 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64742960 |
| 98 | negative regulation of viral genome replication (GO:0045071) | 2.64590478 |
| 99 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.64425063 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63909605 |
| 101 | platelet dense granule organization (GO:0060155) | 2.62484643 |
| 102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.62065498 |
| 103 | regulation of chronic inflammatory response (GO:0002676) | 2.61875800 |
| 104 | regulation of mast cell activation (GO:0033003) | 2.61692340 |
| 105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.61529718 |
| 106 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60623096 |
| 107 | negative T cell selection (GO:0043383) | 2.59805052 |
| 108 | positive regulation of mast cell activation (GO:0033005) | 2.59118975 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.59066577 |
| 110 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59053721 |
| 111 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.58131872 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 2.58071778 |
| 113 | leukocyte degranulation (GO:0043299) | 2.57811192 |
| 114 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.57770682 |
| 115 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57480566 |
| 116 | response to host immune response (GO:0052572) | 2.57480566 |
| 117 | myeloid leukocyte activation (GO:0002274) | 2.57372833 |
| 118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.57302396 |
| 119 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56221224 |
| 120 | dendritic cell differentiation (GO:0097028) | 2.55920871 |
| 121 | protein targeting to ER (GO:0045047) | 2.55856541 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 2.55810601 |
| 123 | negative thymic T cell selection (GO:0045060) | 2.54831138 |
| 124 | cotranslational protein targeting to membrane (GO:0006613) | 2.54805535 |
| 125 | regulation of monocyte chemotaxis (GO:0090025) | 2.54584028 |
| 126 | cellular defense response (GO:0006968) | 2.54543670 |
| 127 | positive regulation of isotype switching (GO:0045830) | 2.54142749 |
| 128 | sequestering of actin monomers (GO:0042989) | 2.53376226 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 2.53360770 |
| 130 | mature B cell differentiation (GO:0002335) | 2.53120912 |
| 131 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52643367 |
| 132 | regulation of regulatory T cell differentiation (GO:0045589) | 2.52458098 |
| 133 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.51965229 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.48565050 |
| 135 | response to interleukin-15 (GO:0070672) | 2.48470470 |
| 136 | regulation of necroptotic process (GO:0060544) | 2.45946215 |
| 137 | ribosomal small subunit biogenesis (GO:0042274) | 2.45011436 |
| 138 | leukocyte cell-cell adhesion (GO:0007159) | 2.44858347 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.43899225 |
| 140 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.43537164 |
| 141 | response to host defenses (GO:0052200) | 2.43480700 |
| 142 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43480700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94584100 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55865111 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87408742 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.86360573 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.46932311 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44627625 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04918264 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.95469476 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89576085 |
| 10 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.86664737 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83619210 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75699520 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75510899 |
| 14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.71634994 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69335384 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.56464082 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54652932 |
| 18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54376232 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.48473059 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45291261 |
| 21 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40444385 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34573139 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13806089 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13475823 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.09589728 |
| 26 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03130413 |
| 27 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02546587 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00877628 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98351960 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94837039 |
| 31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.93954884 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93509940 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.87875254 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87036724 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.86802763 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85130692 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81547846 |
| 38 | * MYC_22102868_ChIP-Seq_BL_Human | 1.78529646 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76835270 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69781817 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.65619249 |
| 42 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57458621 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.57359447 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53589326 |
| 45 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52908451 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52884318 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49576255 |
| 48 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.49312676 |
| 49 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49281701 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48876034 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47660712 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46242111 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41956074 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41219738 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40385821 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39657205 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39631994 |
| 58 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.37363944 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36508611 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35870461 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35612513 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33471614 |
| 63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33258411 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29944857 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26633873 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26275172 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26148386 |
| 68 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25992806 |
| 69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24008368 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23200474 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21461943 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21252396 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21204094 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20539330 |
| 75 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.19351704 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.18270693 |
| 77 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18197543 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18098735 |
| 79 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16968614 |
| 80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16292309 |
| 81 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.16176339 |
| 82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.15546183 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13810711 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13451579 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13182809 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12888685 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11715268 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11605530 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10111443 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09646091 |
| 91 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09420538 |
| 92 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09087637 |
| 93 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08245191 |
| 94 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.07946630 |
| 95 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.07099684 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06540969 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06328656 |
| 98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05824940 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05808438 |
| 100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03176950 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02955382 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02901379 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01312157 |
| 104 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.98779714 |
| 105 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98622927 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98188341 |
| 107 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98126391 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98097598 |
| 109 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97795167 |
| 110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96119793 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96008740 |
| 112 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95583008 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94848908 |
| 114 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94122543 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93409632 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93402474 |
| 117 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92934850 |
| 118 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91880898 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90788083 |
| 120 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.89447771 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88351701 |
| 122 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88266982 |
| 123 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88221420 |
| 124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87531942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.19172908 |
| 2 | MP0003436_decreased_susceptibility_to | 3.46335882 |
| 3 | MP0009785_altered_susceptibility_to | 3.24873357 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.01297407 |
| 5 | MP0000685_abnormal_immune_system | 2.81579604 |
| 6 | MP0002419_abnormal_innate_immunity | 2.79660892 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.76931146 |
| 8 | MP0005025_abnormal_response_to | 2.68705223 |
| 9 | MP0005671_abnormal_response_to | 2.66526946 |
| 10 | MP0003724_increased_susceptibility_to | 2.53557666 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.52627057 |
| 12 | MP0001800_abnormal_humoral_immune | 2.41538337 |
| 13 | MP0001790_abnormal_immune_system | 2.39351744 |
| 14 | MP0005387_immune_system_phenotype | 2.39351744 |
| 15 | MP0002723_abnormal_immune_serum | 2.32938090 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.29104684 |
| 17 | MP0001819_abnormal_immune_cell | 2.28623884 |
| 18 | MP0003303_peritoneal_inflammation | 2.28436233 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.24280122 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.21123862 |
| 21 | MP0006082_CNS_inflammation | 2.20671301 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.19369011 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.09521873 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.05768821 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.04440315 |
| 26 | MP0002405_respiratory_system_inflammati | 2.01757046 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 2.00452663 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.00452663 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.97039434 |
| 30 | MP0002398_abnormal_bone_marrow | 1.95726773 |
| 31 | MP0001853_heart_inflammation | 1.95383812 |
| 32 | MP0000716_abnormal_immune_system | 1.82253618 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.79976125 |
| 34 | MP0002006_tumorigenesis | 1.78389957 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.75992900 |
| 36 | MP0000343_altered_response_to | 1.75594084 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.72427574 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.71847248 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.69438138 |
| 40 | MP0002933_joint_inflammation | 1.67875344 |
| 41 | MP0000858_altered_metastatic_potential | 1.66025122 |
| 42 | MP0003279_aneurysm | 1.62647541 |
| 43 | MP0006054_spinal_hemorrhage | 1.62488982 |
| 44 | MP0002722_abnormal_immune_system | 1.62079804 |
| 45 | MP0002429_abnormal_blood_cell | 1.60317306 |
| 46 | MP0005451_abnormal_body_composition | 1.59594843 |
| 47 | MP0004510_myositis | 1.55859036 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.55648384 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.55186255 |
| 50 | MP0003448_altered_tumor_morphology | 1.55057627 |
| 51 | MP0000490_abnormal_crypts_of | 1.53604058 |
| 52 | MP0009278_abnormal_bone_marrow | 1.49361492 |
| 53 | MP0004947_skin_inflammation | 1.46792298 |
| 54 | MP0008469_abnormal_protein_level | 1.41700723 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.41407060 |
| 56 | MP0001873_stomach_inflammation | 1.39976610 |
| 57 | MP0000604_amyloidosis | 1.39604705 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.31649491 |
| 59 | MP0008260_abnormal_autophagy | 1.30915627 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.28522040 |
| 61 | MP0005390_skeleton_phenotype | 1.27609885 |
| 62 | MP0009764_decreased_sensitivity_to | 1.25733437 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.20079623 |
| 64 | MP0001958_emphysema | 1.16789576 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.15132596 |
| 66 | MP0005023_abnormal_wound_healing | 1.13197999 |
| 67 | MP0005503_abnormal_tendon_morphology | 1.12756583 |
| 68 | MP0003828_pulmonary_edema | 1.06054999 |
| 69 | MP0003186_abnormal_redox_activity | 1.04682444 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.04599207 |
| 71 | MP0005165_increased_susceptibility_to | 1.03869506 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.02688360 |
| 73 | MP0003075_altered_response_to | 1.02130888 |
| 74 | MP0010307_abnormal_tumor_latency | 1.01804580 |
| 75 | MP0008007_abnormal_cellular_replicative | 0.98646435 |
| 76 | MP0003795_abnormal_bone_structure | 0.93715977 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.93187190 |
| 78 | MP0004883_abnormal_blood_vessel | 0.91425084 |
| 79 | MP0003866_abnormal_defecation | 0.89792568 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.89562099 |
| 81 | MP0005275_abnormal_skin_tensile | 0.89523294 |
| 82 | MP0001851_eye_inflammation | 0.89352552 |
| 83 | MP0005310_abnormal_salivary_gland | 0.88670521 |
| 84 | MP0001542_abnormal_bone_strength | 0.88335250 |
| 85 | MP0008004_abnormal_stomach_pH | 0.87545522 |
| 86 | MP0005166_decreased_susceptibility_to | 0.83646312 |
| 87 | MP0002132_abnormal_respiratory_system | 0.83410503 |
| 88 | MP0003693_abnormal_embryo_hatching | 0.81612866 |
| 89 | MP0009763_increased_sensitivity_to | 0.81462299 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.80697270 |
| 91 | MP0005164_abnormal_response_to | 0.79194557 |
| 92 | MP0000249_abnormal_blood_vessel | 0.77883944 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.77629232 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.76769419 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.74729452 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.73696380 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.72479603 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.72365163 |
| 99 | MP0002254_reproductive_system_inflammat | 0.71052787 |
| 100 | MP0001243_abnormal_dermal_layer | 0.70462298 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.69889350 |
| 102 | MP0003329_amyloid_beta_deposits | 0.69806917 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 0.68700896 |
| 104 | MP0001663_abnormal_digestive_system | 0.67488589 |
| 105 | MP0003091_abnormal_cell_migration | 0.66747818 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.66744047 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.64941439 |
| 108 | MP0003045_fibrosis | 0.64478680 |
| 109 | MP0003077_abnormal_cell_cycle | 0.64216845 |
| 110 | MP0009840_abnormal_foam_cell | 0.60033866 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.59960382 |
| 112 | MP0000313_abnormal_cell_death | 0.59538106 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.59015477 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.58522145 |
| 115 | MP0000920_abnormal_myelination | 0.58383090 |
| 116 | MP0003690_abnormal_glial_cell | 0.57317027 |
| 117 | MP0002113_abnormal_skeleton_development | 0.56107096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.88923215 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.14103142 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.03004147 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.82515446 |
| 5 | Myositis (HP:0100614) | 4.27255168 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.76269321 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.71743185 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.67541198 |
| 9 | Petechiae (HP:0000967) | 3.60877385 |
| 10 | Thrombocytosis (HP:0001894) | 3.58147322 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.56760169 |
| 12 | Recurrent skin infections (HP:0001581) | 3.29157905 |
| 13 | Chronic otitis media (HP:0000389) | 3.27254229 |
| 14 | Cellulitis (HP:0100658) | 3.24226207 |
| 15 | Increased IgM level (HP:0003496) | 3.23303007 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18876219 |
| 17 | Obstructive lung disease (HP:0006536) | 3.18876219 |
| 18 | Orchitis (HP:0100796) | 3.15025969 |
| 19 | T lymphocytopenia (HP:0005403) | 3.14804251 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.14362451 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.14258980 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.10280601 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.09682568 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.07339920 |
| 25 | Recurrent viral infections (HP:0004429) | 3.02946874 |
| 26 | IgM deficiency (HP:0002850) | 2.99679195 |
| 27 | Abnormality of T cell number (HP:0011839) | 2.93453285 |
| 28 | Amyloidosis (HP:0011034) | 2.87523420 |
| 29 | Increased serum ferritin (HP:0003281) | 2.84743244 |
| 30 | Hepatosplenomegaly (HP:0001433) | 2.80582667 |
| 31 | Gingivitis (HP:0000230) | 2.68714295 |
| 32 | Meningitis (HP:0001287) | 2.65550453 |
| 33 | Basal ganglia calcification (HP:0002135) | 2.64122300 |
| 34 | Optic neuritis (HP:0100653) | 2.63938899 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.63938899 |
| 36 | Pustule (HP:0200039) | 2.62940569 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.58491690 |
| 38 | Prolonged bleeding time (HP:0003010) | 2.57298729 |
| 39 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.56657726 |
| 40 | Abnormal number of erythroid precursors (HP:0012131) | 2.56055662 |
| 41 | Encephalitis (HP:0002383) | 2.53736477 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.53534245 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.53213554 |
| 44 | Vasculitis (HP:0002633) | 2.51458150 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.51367086 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.50659374 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.48137031 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44536107 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44536107 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44536107 |
| 51 | Stomatitis (HP:0010280) | 2.43223071 |
| 52 | Poor head control (HP:0002421) | 2.42266785 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.41650049 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.41302887 |
| 55 | Beaking of vertebral bodies (HP:0004568) | 2.38618464 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.35325631 |
| 57 | Nasal polyposis (HP:0100582) | 2.34758593 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.33933894 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.33933894 |
| 60 | Episodic fever (HP:0001954) | 2.32763287 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.32129739 |
| 62 | Reticulocytopenia (HP:0001896) | 2.31668110 |
| 63 | Cervical subluxation (HP:0003308) | 2.31560395 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.31467697 |
| 65 | Purpura (HP:0000979) | 2.30019812 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.29728875 |
| 67 | Epistaxis (HP:0000421) | 2.29542818 |
| 68 | Aplastic anemia (HP:0001915) | 2.28907823 |
| 69 | Hypertensive crisis (HP:0100735) | 2.28761422 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.27360610 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.26586685 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.24406610 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.24331797 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24331797 |
| 75 | Chest pain (HP:0100749) | 2.22211993 |
| 76 | Myocardial infarction (HP:0001658) | 2.21020600 |
| 77 | Leukocytosis (HP:0001974) | 2.20116535 |
| 78 | Peritonitis (HP:0002586) | 2.17659686 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.17632620 |
| 80 | Disinhibition (HP:0000734) | 2.17419768 |
| 81 | Urticaria (HP:0001025) | 2.17197941 |
| 82 | Periodontitis (HP:0000704) | 2.17178268 |
| 83 | Granulocytopenia (HP:0001913) | 2.15937536 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.13943831 |
| 85 | Glomerulopathy (HP:0100820) | 2.13348296 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.12822033 |
| 87 | IgG deficiency (HP:0004315) | 2.11030457 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.10974210 |
| 89 | Abnormality of T cells (HP:0002843) | 2.10837673 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.10430282 |
| 91 | Osteomyelitis (HP:0002754) | 2.09981048 |
| 92 | Increased IgE level (HP:0003212) | 2.07187117 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.07164983 |
| 94 | Joint stiffness (HP:0001387) | 2.04873894 |
| 95 | Spondylolisthesis (HP:0003302) | 2.03819911 |
| 96 | Agnosia (HP:0010524) | 2.02317430 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02124581 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.02124581 |
| 99 | Biconcave vertebral bodies (HP:0004586) | 2.00913455 |
| 100 | Axonal loss (HP:0003447) | 2.00871455 |
| 101 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99046102 |
| 102 | Abnormality of the pericardium (HP:0001697) | 1.98799596 |
| 103 | Arterial thrombosis (HP:0004420) | 1.96654771 |
| 104 | Lymphopenia (HP:0001888) | 1.95978995 |
| 105 | Glomerulonephritis (HP:0000099) | 1.94104095 |
| 106 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94042898 |
| 107 | Spinal cord lesions (HP:0100561) | 1.93912269 |
| 108 | Syringomyelia (HP:0003396) | 1.93912269 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93197538 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93197538 |
| 111 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93197538 |
| 112 | Abnormal platelet function (HP:0011869) | 1.90461390 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.90461390 |
| 114 | Panhypogammaglobulinemia (HP:0003139) | 1.90247743 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 1.89605090 |
| 116 | Gingival bleeding (HP:0000225) | 1.89551459 |
| 117 | Prostate neoplasm (HP:0100787) | 1.89522070 |
| 118 | Pallor (HP:0000980) | 1.87639325 |
| 119 | Hemoptysis (HP:0002105) | 1.86753268 |
| 120 | Arthralgia (HP:0002829) | 1.86403539 |
| 121 | Anorexia (HP:0002039) | 1.85601195 |
| 122 | Gangrene (HP:0100758) | 1.85394918 |
| 123 | Acrocyanosis (HP:0001063) | 1.85282969 |
| 124 | Skin ulcer (HP:0200042) | 1.84835430 |
| 125 | Thoracic kyphosis (HP:0002942) | 1.84371650 |
| 126 | Polyneuropathy (HP:0001271) | 1.83092364 |
| 127 | Dilatation of the ascending aorta (HP:0005111) | 1.83035229 |
| 128 | Agammaglobulinemia (HP:0004432) | 1.82982774 |
| 129 | Type I transferrin isoform profile (HP:0003642) | 1.82275699 |
| 130 | Premature rupture of membranes (HP:0001788) | 1.81925962 |
| 131 | Eosinophilia (HP:0001880) | 1.81738119 |
| 132 | Fatigue (HP:0012378) | 1.81494649 |
| 133 | Loss of speech (HP:0002371) | 1.81487874 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.79602409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.07680023 |
| 2 | MAP4K1 | 3.30612297 |
| 3 | KIT | 3.23328011 |
| 4 | PIM2 | 2.99788610 |
| 5 | BLK | 2.87554266 |
| 6 | TBK1 | 2.77672152 |
| 7 | IRAK4 | 2.69900475 |
| 8 | MAP3K14 | 2.39923021 |
| 9 | TXK | 2.26084046 |
| 10 | TYK2 | 2.22070539 |
| 11 | JAK3 | 2.20099715 |
| 12 | ERN1 | 2.11629335 |
| 13 | IKBKE | 2.06964939 |
| 14 | PRPF4B | 2.06024225 |
| 15 | TEC | 2.01775686 |
| 16 | BTK | 1.94456122 |
| 17 | GRK7 | 1.88229435 |
| 18 | ZAP70 | 1.86069656 |
| 19 | IKBKB | 1.80841743 |
| 20 | RIPK4 | 1.77540098 |
| 21 | MAP2K3 | 1.74860990 |
| 22 | CSF1R | 1.70078400 |
| 23 | IRAK3 | 1.65179407 |
| 24 | RPS6KA4 | 1.64571388 |
| 25 | TGFBR2 | 1.48839943 |
| 26 | LIMK1 | 1.48596287 |
| 27 | SYK | 1.44329717 |
| 28 | KDR | 1.44047414 |
| 29 | PIM1 | 1.39125478 |
| 30 | LRRK2 | 1.37164508 |
| 31 | FLT3 | 1.35017038 |
| 32 | BMPR2 | 1.31264192 |
| 33 | TRIB3 | 1.23026683 |
| 34 | STK10 | 1.20840686 |
| 35 | NEK9 | 1.19914542 |
| 36 | LYN | 1.19576826 |
| 37 | ARAF | 1.18947674 |
| 38 | ACVR1B | 1.16372994 |
| 39 | TRPM7 | 1.15585852 |
| 40 | HCK | 1.14325223 |
| 41 | TGFBR1 | 1.14204495 |
| 42 | TESK2 | 1.13935150 |
| 43 | TAOK1 | 1.13322675 |
| 44 | LCK | 1.10627407 |
| 45 | FGR | 1.10022004 |
| 46 | JAK1 | 1.07704700 |
| 47 | SCYL2 | 1.04266979 |
| 48 | CSK | 1.02891029 |
| 49 | MAP3K1 | 1.00869994 |
| 50 | DDR2 | 1.00145508 |
| 51 | BCKDK | 0.99070675 |
| 52 | CLK1 | 0.97227342 |
| 53 | TAOK3 | 0.95237224 |
| 54 | PKN2 | 0.94995410 |
| 55 | SIK3 | 0.93047043 |
| 56 | MATK | 0.88864735 |
| 57 | CHUK | 0.87537190 |
| 58 | EIF2AK1 | 0.87209917 |
| 59 | FES | 0.85729390 |
| 60 | TTN | 0.84657459 |
| 61 | MAP3K3 | 0.83238758 |
| 62 | TESK1 | 0.80948201 |
| 63 | VRK2 | 0.80507569 |
| 64 | EIF2AK3 | 0.80229941 |
| 65 | ABL2 | 0.79712124 |
| 66 | MAP3K12 | 0.79289444 |
| 67 | MAP3K11 | 0.78241017 |
| 68 | PAK4 | 0.76578202 |
| 69 | ITK | 0.76446219 |
| 70 | PRKG2 | 0.74691594 |
| 71 | EEF2K | 0.71821053 |
| 72 | CAMKK2 | 0.71672265 |
| 73 | NLK | 0.70207437 |
| 74 | ILK | 0.68436776 |
| 75 | CDC42BPA | 0.66035735 |
| 76 | WEE1 | 0.60587194 |
| 77 | RPS6KA6 | 0.60414731 |
| 78 | PRKD2 | 0.60298477 |
| 79 | MYLK | 0.60103355 |
| 80 | HIPK2 | 0.58420353 |
| 81 | STK4 | 0.58399317 |
| 82 | MAP3K5 | 0.58052379 |
| 83 | PAK1 | 0.57954713 |
| 84 | VRK1 | 0.56467692 |
| 85 | BRSK2 | 0.56404505 |
| 86 | EIF2AK2 | 0.55828239 |
| 87 | MOS | 0.54028209 |
| 88 | PBK | 0.53933771 |
| 89 | ADRBK2 | 0.53361925 |
| 90 | MARK3 | 0.52879832 |
| 91 | PIK3CG | 0.52838529 |
| 92 | MAPKAPK2 | 0.50947610 |
| 93 | DAPK1 | 0.50509453 |
| 94 | PRKCD | 0.50475129 |
| 95 | TAOK2 | 0.50154324 |
| 96 | JAK2 | 0.49553039 |
| 97 | CDK7 | 0.48508946 |
| 98 | DAPK3 | 0.47627294 |
| 99 | MUSK | 0.47272081 |
| 100 | RPS6KC1 | 0.45834271 |
| 101 | RPS6KL1 | 0.45834271 |
| 102 | ABL1 | 0.45809908 |
| 103 | STK16 | 0.45804683 |
| 104 | RIPK1 | 0.45618454 |
| 105 | GRK6 | 0.45263688 |
| 106 | MAPKAPK3 | 0.43315553 |
| 107 | PTK2B | 0.42114509 |
| 108 | MAP3K8 | 0.41714130 |
| 109 | FGFR3 | 0.40738420 |
| 110 | BMX | 0.40458784 |
| 111 | TNK2 | 0.40143285 |
| 112 | CDK4 | 0.39706116 |
| 113 | RAF1 | 0.39683656 |
| 114 | MAPK11 | 0.39662134 |
| 115 | CDK6 | 0.38796930 |
| 116 | EPHB1 | 0.38763910 |
| 117 | BUB1 | 0.38371848 |
| 118 | MAPK4 | 0.38142445 |
| 119 | PRKCQ | 0.37892131 |
| 120 | FYN | 0.37775227 |
| 121 | ERBB3 | 0.37062628 |
| 122 | EPHA3 | 0.36899776 |
| 123 | CDK8 | 0.35942745 |
| 124 | RPS6KA5 | 0.34972044 |
| 125 | MAP3K13 | 0.34491272 |
| 126 | PDK1 | 0.33852576 |
| 127 | PDPK1 | 0.30515017 |
| 128 | IRAK2 | 0.28462152 |
| 129 | MAPK7 | 0.27837953 |
| 130 | SIK1 | 0.26867905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86920122 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51883706 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.40244171 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.16310652 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06584445 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.02901302 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.00771102 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.99554903 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.99121578 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98004888 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95540918 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95090310 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.94602822 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90823335 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87902087 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82273619 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82117893 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75456643 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75453257 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74827105 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.73438887 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.66752491 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66484704 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.64138525 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63612677 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60321054 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58645020 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57981730 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53901498 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.52116665 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.48070154 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.46183915 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.45339157 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.43894417 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.36779602 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36609743 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.35183900 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30061908 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29445110 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28092718 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.24945350 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 1.23260501 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22731743 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.21966832 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19743092 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15255774 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13966352 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11369339 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 1.05683665 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.03051792 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02903295 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02123398 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01139261 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98006054 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96718260 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95079764 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94281162 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92784315 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90965476 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 0.87276781 |
| 61 | Protein export_Homo sapiens_hsa03060 | 0.86358742 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86281774 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84792838 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84294503 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82912430 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78875053 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77816789 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.74102492 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.73899067 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.73843451 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73565788 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68840620 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68397810 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68349523 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67737043 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66491826 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66228798 |
| 78 | Spliceosome_Homo sapiens_hsa03040 | 0.65569505 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65535123 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.64666516 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.64545058 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63448352 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62570480 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.62254753 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60271774 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59618904 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57069065 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56196277 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55947087 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55558500 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55427193 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53281650 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51923868 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50164693 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48984708 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48859745 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46235679 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46214384 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45269183 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44663373 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44119910 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44082294 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.43522882 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42817204 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.41597784 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40710072 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39541040 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38903857 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37829360 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36570751 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35655129 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33775010 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33542878 |
| 114 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32146464 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27836562 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21402993 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19431738 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18228847 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18039070 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.15379565 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.15355034 |

